Interact to see
Advertisement
Advertisement
HGHRX vs VGHCX
HGHRX vs VGHCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
HGHRX vs. VGHCX commentary
Jan 15, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHRX is a StrongBuy and VGHCX is a Hold.
FUNDAMENTALS
Fundamentals
VGHCX has more cash in the bank: 39.6B vs. HGHRX (855M). VGHCX pays higher dividends than HGHRX: VGHCX (1.00) vs HGHRX (0.00). HGHRX was incepted earlier than VGHCX: HGHRX (19 years) vs VGHCX (42 years). HGHRX (1.63) is less costly to investors than VGHCX (0.37). HGHRX is a more actively managed with annual turnover of: 40.00 vs. VGHCX (29.00). HGHRX has a lower initial minimum investment than VGHCX: HGHRX (0) vs VGHCX (3000). VGHCX annual gain was more profitable for investors over the last year : 14.46 vs. HGHRX (12.52). VGHCX return over 5 years is better than : -5.27 vs. HGHRX (-7.91).
| HGHRX | VGHCX | HGHRX / VGHCX | |
| Total Expense Ratio | 1.63 | 0.37 | 441% |
| Annual Report Gross Expense Ratio | 1.63 | 0.37 | 441% |
| Fund Existence | 19 years | 42 years | - |
| Gain YTD | 2.131 | 2.483 | 86% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 855M | 39.6B | 2% |
| Annual Yield % from dividends | 0.00 | 1.00 | - |
| Returns for 1 year | 12.52 | 14.46 | 87% |
| Returns for 3 years | 10.67 | -1.84 | -581% |
| Returns for 5 years | -7.91 | -5.27 | 150% |
| Returns for 10 years | 24.57 | 4.58 | 537% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement